Table 3.

Administered BMA and administration period.

Patient	Right or Left	Administered BMA prior to AFF diagnosis	BMA administration period before AFF surgery (months)
1	Right	Zoledronic acid	39.0
	Left	Zoledronic acid → Denosumab	73.0
2	Left	Zoledronic acid	41.0
	Right	Zoledronic acid	41.0
3	Right	Zoledronic acid → Denosumab	76.0
	Left	Zoledronic acid → Denosumab	76.0
4	Right	Zoledronic acid	84.5
5	Left	Zoledronic acid	17.2
6	Right	Zoledronic acid	30.0
7	Right	Zoledronic acid	57.1
	Left	Denosumab	45.1
8	Left	Zoledronic acid → Denosumab	91.4
	Right	Zoledronic acid → Denosumab	61.9
9	Right	Denosumab → Zoledronic acid	71.7
	Left	Denosumab → Zoledronic acid	65.4
10	Right	Zoledronic acid → Denosumab	150.6
	Left	Zoledronic acid → Denosumab	156.9
11	Right	Zoledronic acid	75.8
12	Right	Zoledronic acid → Denosumab	25.9
13	Right	Zoledronic acid	49.4
14	Left	Zoledronic acid → Denosumab	124.7
15	Right	Zoledronic acid	75.6
	Left	Zoledronic acid	85.7
16	Right	Zoledronic acid → Denosumab	108.9
	Left	Zoledronic acid → Denosumab	108.9
17	Left	Zoledronic acid	181.0
	Right	Zoledronic acid	90.0
18	Left	Zoledronic acid → Denosumab	28.8
19	Right	Zoledronic acid → Denosumab → Zoledronic acid → Denosumab	47.6
	Left	Zoledronic acid → Denosumab → Zoledronic acid → Denosumab	77.4